Al[¹⁸F]F-NOTA-Octreotide & [⁶⁸Ga]Ga-DOTA-TATE for PET/CT Imaging of Neuroendocrine Tumors in Latin America

In the present work we investigated the clinical utility of Al[¹⁸F]F-NOTAOctreotide (Al[¹⁸F]F-OC) in comparison to [⁶⁸Ga]Ga-DOTA-TATE in patients diagnosed with neuroendocrine tumours. Our aim was to verify the recently published, promising results for Al[¹⁸F]FNOTA-Octreotide in the Latin-American population. Al[¹⁸F]F-NOTA-Octreotide provided excellent image quality, detected NET lesions with high sensitivity and represents a highly promising, clinical alternative to [⁶⁸Ga]Ga-DOTA-TATE.